- Home
- ZURA vs TLS Comparison
ZURA vs TLS Comparison
Compare ZURA & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- TLS
- Stock Information
- Founded
- ZURA 2022
- TLS 1969
- Country
- ZURA United States
- TLS United States
- Employees
- ZURA N/A
- TLS N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- TLS EDP Services
- Sector
- ZURA Health Care
- TLS Technology
- Exchange
- ZURA Nasdaq
- TLS Nasdaq
- Market Cap
- ZURA 69.9M
- TLS 199.9M
- IPO Year
- ZURA N/A
- TLS 2020
- Fundamental
- Price
- ZURA $1.91
- TLS $2.84
- Analyst Decision
- ZURA Buy
- TLS Buy
- Analyst Count
- ZURA 7
- TLS 6
- Target Price
- ZURA $14.33
- TLS $3.94
- AVG Volume (30 Days)
- ZURA 1.2M
- TLS 1.1M
- Earning Date
- ZURA 08-08-2025
- TLS 08-08-2025
- Dividend Yield
- ZURA N/A
- TLS N/A
- EPS Growth
- ZURA N/A
- TLS N/A
- EPS
- ZURA N/A
- TLS N/A
- Revenue
- ZURA N/A
- TLS $109,269,000.00
- Revenue This Year
- ZURA N/A
- TLS $35.76
- Revenue Next Year
- ZURA N/A
- TLS $26.83
- P/E Ratio
- ZURA N/A
- TLS N/A
- Revenue Growth
- ZURA N/A
- TLS N/A
- 52 Week Low
- ZURA $0.97
- TLS $1.83
- 52 Week High
- ZURA $5.07
- TLS $4.82
- Technical
- Relative Strength Index (RSI)
- ZURA 77.68
- TLS 52.64
- Support Level
- ZURA $1.26
- TLS $2.67
- Resistance Level
- ZURA $1.45
- TLS $3.01
- Average True Range (ATR)
- ZURA 0.16
- TLS 0.18
- MACD
- ZURA 0.08
- TLS -0.03
- Stochastic Oscillator
- ZURA 77.12
- TLS 38.89
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.